New to Meducation?
Sign up
Already signed up? Log In
view moderators

HeartDiseases

Category

Preview
12
317

Cardiomyopathies Study Notes

Includes symptoms, some investigations and treatment and management for HCM, RCM, DCM and ARVC.  
Laura R Barry
over 5 years ago
Preview
5
260

Congenital Acyanotic Heart Disease

Acyanotic Heart Disease Left to Right Shunt  
kellie Bateman
over 4 years ago
Preview
1
28

Cardiology - Wikipedia, the free encyclopedia

Cardiology (from Greek καρδίᾱ kardiā, "heart" and -λογία -logia, "study") is a branch of medicine dealing with disorders of the heart. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease and electrophysiology. Physicians who specialize in this field of medicine are called cardiologists, a specialty of internal medicine. Pediatric cardiologists are pediatricians who specialize in cardiology. Physicians who specialize in cardiac surgery are called cardiothoracic surgeons or cardiac surgeons, a specialty of general surgery.  
en.wikipedia.org
over 5 years ago
Preview
1
10

Cardiac Arrest

 
almostadoctor.com - free medical student revision notes
over 5 years ago
Preview
3
115

Heart Failure

Heart Failure is... Inability of the heart to pump adequate amounts of blood to meet the body's metabolic demands End stage of all heart diseases Accounts for 5 in 1000 hospital admission each year in the UK   Terms;  
almostadoctor.com - free medical student revision notes
over 5 years ago
Preview
2
53

Aortic Stenosis

Causes Congenital Bicuspid Valve Williams Syndrome Senile Calcification THE most common cause Look for corneal arcus   Signs  
almostadoctor.com - free medical student revision notes
over 5 years ago
Preview
3
94

Infective Endocarditis

This is a condition caused by infection of the endocardium by bacteria, or rarely, fungus. It most commonly affects the heart valves (natural or prosthetic), but can occur anywhere along the lining of the heart or blood vessels. It will most commonly occur at sites of previous damage, however, particularly virulent organisms (such as staphylococcus aureus and streptococcus pneumoniae) can infect previously normal areas of tissue; for example, Staph. Aureus will commonly infect the tricuspid valve in IV drug users.    
almostadoctor.com - free medical student revision notes
over 5 years ago
Preview
1
24

Bypass Surgery (CABG)

By-pass surgery - CABG Along with angioplasty this is the other coronary revascularisation technique used for the treatment of IHD (ischaemic heart disease).   Indications  
almostadoctor.com - free medical student revision notes
over 5 years ago
Preview
1
36

Pericarditis

The normal pericardium This contains about 50ml of fluid, and help lubricate the movement of the heart. It helps to: Limit distension of the heart Protect the heart from infection / damage Aids the filling of the ventricles However – congenital defects of the pericardium do not appear to have much impact on heart function.   Acute Pericarditis Causes  
almostadoctor.com - free medical student revision notes
over 5 years ago
Preview
2
66

Congenital Cyanotic Heart Disease

Congenital cyanotic heart disease – aka blue baby syndrome These account for about 25% of all congenital heart defects   Causes – there are lots more! In the exam, you might be asked to examine a child, and be expected to come to a conclusion of ‘congenital cyanotic heart disease’, and then give a few examples of what can cause it:  
almostadoctor.com - free medical student revision notes
over 5 years ago
Preview
1
14

PDA - Patent Ductus Arteriosus

PDA – Patent Ductus Arteriosus – L-to-R shunt – ACYANOTIC Treatment Usually treated even if asymptomatic to reduce the risk of infective endocarditis  
almostadoctor.com - free medical student revision notes
over 5 years ago
Preview
1
15

Tetralogy of Falot

Tetralogy of Falot – R-to-L shunt – CYANOTICTHE most common cause of cyanotic heart disease – but only accounts for  
almostadoctor.com - free medical student revision notes
over 5 years ago
Preview
0
7

Health atlas allows online search of risk by area - BBC News

A new online map of England and Wales allows people to enter their postcode and find their community's level of risk of developing 14 conditions, such as heart disease and lung cancer.  
BBC News
over 5 years ago
Www.bmj
1
28

Anticoagulation in atrial fibrillation

Atrial fibrillation increases the risk of stroke, which is a leading cause of death and disability worldwide. The use of oral anticoagulation in patients with atrial fibrillation at moderate or high risk of stroke, estimated by established criteria, improves outcomes. However, to ensure that the benefits exceed the risks of bleeding, appropriate patient selection is essential. Vitamin K antagonism has been the mainstay of treatment; however, newer drugs with novel mechanisms are also available. These novel oral anticoagulants (direct thrombin inhibitors and factor Xa inhibitors) obviate many of warfarin’s shortcomings, and they have demonstrated safety and efficacy in large randomized trials of patients with non-valvular atrial fibrillation. However, the management of patients taking warfarin or novel agents remains a clinical challenge. There are several important considerations when selecting anticoagulant therapy for patients with atrial fibrillation. This review will discuss the rationale for anticoagulation in patients with atrial fibrillation; risk stratification for treatment; available agents; the appropriate implementation of these agents; and additional, specific clinical considerations for treatment.  
bmj.com
over 5 years ago
Www.bmj
1
19

Anticoagulation in atrial fibrillation

Atrial fibrillation increases the risk of stroke, which is a leading cause of death and disability worldwide. The use of oral anticoagulation in patients with atrial fibrillation at moderate or high risk of stroke, estimated by established criteria, improves outcomes. However, to ensure that the benefits exceed the risks of bleeding, appropriate patient selection is essential. Vitamin K antagonism has been the mainstay of treatment; however, newer drugs with novel mechanisms are also available. These novel oral anticoagulants (direct thrombin inhibitors and factor Xa inhibitors) obviate many of warfarin’s shortcomings, and they have demonstrated safety and efficacy in large randomized trials of patients with non-valvular atrial fibrillation. However, the management of patients taking warfarin or novel agents remains a clinical challenge. There are several important considerations when selecting anticoagulant therapy for patients with atrial fibrillation. This review will discuss the rationale for anticoagulation in patients with atrial fibrillation; risk stratification for treatment; available agents; the appropriate implementation of these agents; and additional, specific clinical considerations for treatment.  
bmj.com
over 5 years ago
Www.bmj
1
11

Married women have lower risk of dying from heart disease than single women, says UK study

Women who are married or living with a partner have a similar risk of developing ischaemic heart disease to unmarried women but a substantially lower risk of dying from it, data from the Million Women cohort have shown.1  
bmj.com
over 5 years ago
Www.bmj
1
18

Anticoagulation in atrial fibrillation

Atrial fibrillation increases the risk of stroke, which is a leading cause of death and disability worldwide. The use of oral anticoagulation in patients with atrial fibrillation at moderate or high risk of stroke, estimated by established criteria, improves outcomes. However, to ensure that the benefits exceed the risks of bleeding, appropriate patient selection is essential. Vitamin K antagonism has been the mainstay of treatment; however, newer drugs with novel mechanisms are also available. These novel oral anticoagulants (direct thrombin inhibitors and factor Xa inhibitors) obviate many of warfarin’s shortcomings, and they have demonstrated safety and efficacy in large randomized trials of patients with non-valvular atrial fibrillation. However, the management of patients taking warfarin or novel agents remains a clinical challenge. There are several important considerations when selecting anticoagulant therapy for patients with atrial fibrillation. This review will discuss the rationale for anticoagulation in patients with atrial fibrillation; risk stratification for treatment; available agents; the appropriate implementation of these agents; and additional, specific clinical considerations for treatment.  
bmj.com
over 5 years ago
Www.bmj
1
30

Is adrenaline safe and effective as a treatment for out of hospital cardiac arrest?

Adrenaline (epinephrine) has been an integral component of advanced resuscitation algorithms since the early 1960s. Initial guidelines for the treatment of cardiac arrest recommended the use of intracardiac adrenaline (0.5 mg) or high dose intravenous adrenaline (10 mg), repeating with larger doses if required.1 The mechanism of action for adrenaline in cardiac arrest is attributed to stimulation of α2 receptors in vascular smooth muscle, causing vasoconstriction. This increases aortic diastolic pressure, which in turn leads to increased coronary perfusion pressures, which improves short term survival. Experimental studies, however, suggest that adrenaline impairs cerebral macrovascular2 and microvascular blood flow,3 4 increases ventricular arrhythmias, and increases myocardial dysfunction after return of spontaneous circulation.5 This creates the paradox of better short term survival but at the potential cost of worse long term outcomes.  
bmj.com
over 5 years ago
Www.bmj
3
131

Anticoagulation in atrial fibrillation

Atrial fibrillation increases the risk of stroke, which is a leading cause of death and disability worldwide. The use of oral anticoagulation in patients with atrial fibrillation at moderate or high risk of stroke, estimated by established criteria, improves outcomes. However, to ensure that the benefits exceed the risks of bleeding, appropriate patient selection is essential. Vitamin K antagonism has been the mainstay of treatment; however, newer drugs with novel mechanisms are also available. These novel oral anticoagulants (direct thrombin inhibitors and factor Xa inhibitors) obviate many of warfarin’s shortcomings, and they have demonstrated safety and efficacy in large randomized trials of patients with non-valvular atrial fibrillation. However, the management of patients taking warfarin or novel agents remains a clinical challenge. There are several important considerations when selecting anticoagulant therapy for patients with atrial fibrillation. This review will discuss the rationale for anticoagulation in patients with atrial fibrillation; risk stratification for treatment; available agents; the appropriate implementation of these agents; and additional, specific clinical considerations for treatment.  
bmj.com
over 5 years ago